248 related articles for article (PubMed ID: 35459469)
1. Origin, activation and heterogeneity of fibroblasts associated with pancreas and breast cancers.
Han L; Seward C; Leone G; Ostrowski MC
Adv Cancer Res; 2022; 154():169-201. PubMed ID: 35459469
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic Fibroblast Heterogeneity: From Development to Cancer.
Garcia PE; Scales MK; Allen BL; Pasca di Magliano M
Cells; 2020 Nov; 9(11):. PubMed ID: 33198201
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.
González L; Eiro N; Fernandez-Garcia B; González LO; Dominguez F; Vizoso FJ
Mol Carcinog; 2016 Nov; 55(11):1489-1502. PubMed ID: 26349857
[TBL] [Abstract][Full Text] [Related]
4. Breast Cancer CAFs: Spectrum of Phenotypes and Promising Targeting Avenues.
Elwakeel E; Weigert A
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769066
[TBL] [Abstract][Full Text] [Related]
5. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis.
Zhang W; Wang J; Liu C; Li Y; Sun C; Wu J; Wu Q
J Transl Med; 2023 Nov; 21(1):827. PubMed ID: 37978384
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
Ravichandra A; Bhattacharjee S; Affò S
Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
[TBL] [Abstract][Full Text] [Related]
8. The role of cancer-associated fibroblasts in breast cancer pathobiology.
Jung YY; Kim HM; Koo JS
Histol Histopathol; 2016 Apr; 31(4):371-8. PubMed ID: 26627101
[TBL] [Abstract][Full Text] [Related]
9. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
Yoshida GJ
J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts in breast cancer: Challenges and opportunities.
Hu D; Li Z; Zheng B; Lin X; Pan Y; Gong P; Zhuo W; Hu Y; Chen C; Chen L; Zhou J; Wang L
Cancer Commun (Lond); 2022 May; 42(5):401-434. PubMed ID: 35481621
[TBL] [Abstract][Full Text] [Related]
11. The Origin, Differentiation, and Functions of Cancer-Associated Fibroblasts in Gastrointestinal Cancer.
Huang J; Tsang WY; Li ZH; Guan XY
Cell Mol Gastroenterol Hepatol; 2023; 16(4):503-511. PubMed ID: 37451403
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Martinez-Zubiaurre I; Hellevik T
Cell Commun Signal; 2023 May; 21(1):108. PubMed ID: 37170098
[TBL] [Abstract][Full Text] [Related]
13. Biological characteristics and genetic heterogeneity between carcinoma-associated fibroblasts and their paired normal fibroblasts in human breast cancer.
Peng Q; Zhao L; Hou Y; Sun Y; Wang L; Luo H; Peng H; Liu M
PLoS One; 2013; 8(4):e60321. PubMed ID: 23577100
[TBL] [Abstract][Full Text] [Related]
14. [Cancer-Associated Fibroblasts: Heterogeneity and Bimodality in Oncogenesis].
Lunina NA; Safina DR; Kostrov SV
Mol Biol (Mosk); 2023; 57(5):739-770. PubMed ID: 37752641
[TBL] [Abstract][Full Text] [Related]
15. Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer.
Salimifard S; Masjedi A; Hojjat-Farsangi M; Ghalamfarsa G; Irandoust M; Azizi G; Mohammadi H; Keramati MR; Jadidi-Niaragh F
Pathol Res Pract; 2020 May; 216(5):152915. PubMed ID: 32146002
[TBL] [Abstract][Full Text] [Related]
16. Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors.
Djurec M; Graña O; Lee A; Troulé K; Espinet E; Cabras L; Navas C; Blasco MT; Martín-Díaz L; Burdiel M; Li J; Liu Z; Vallespinós M; Sanchez-Bueno F; Sprick MR; Trumpp A; Sainz B; Al-Shahrour F; Rabadan R; Guerra C; Barbacid M
Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1147-E1156. PubMed ID: 29351990
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment.
Houthuijzen JM; Jonkers J
Cancer Metastasis Rev; 2018 Dec; 37(4):577-597. PubMed ID: 30465162
[TBL] [Abstract][Full Text] [Related]
18. GPER is involved in the functional liaison between breast tumor cells and cancer-associated fibroblasts (CAFs).
Lappano R; Maggiolini M
J Steroid Biochem Mol Biol; 2018 Feb; 176():49-56. PubMed ID: 28249728
[TBL] [Abstract][Full Text] [Related]
19. A Human Organotypic Microfluidic Tumor Model Permits Investigation of the Interplay between Patient-Derived Fibroblasts and Breast Cancer Cells.
Truong DD; Kratz A; Park JG; Barrientos ES; Saini H; Nguyen T; Pockaj B; Mouneimne G; LaBaer J; Nikkhah M
Cancer Res; 2019 Jun; 79(12):3139-3151. PubMed ID: 30992322
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts: A key target to snatch victory from defeat in therapy resistance associated with the pancreatic cancer stroma.
Luo W; Zhang T
Cancer Lett; 2023 Jul; 567():216279. PubMed ID: 37336287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
